Anti-Fibrotic Effects of Class I HDAC Inhibitor, Mocetinostat Is Associated with IL-6/Stat3 Signaling in Ischemic Heart Failure (Q35723859)

From Wikidata
Jump to navigation Jump to search
scientific article published on 19 May 2015
edit
Language Label Description Also known as
English
Anti-Fibrotic Effects of Class I HDAC Inhibitor, Mocetinostat Is Associated with IL-6/Stat3 Signaling in Ischemic Heart Failure
scientific article published on 19 May 2015

    Statements

    Anti-Fibrotic Effects of Class I HDAC Inhibitor, Mocetinostat Is Associated with IL-6/Stat3 Signaling in Ischemic Heart Failure (English)
    Hikmet Nural-Guvener
    Liudmila Zakharova
    Lorraine Feehery
    Snjezana Sljukic
    Mohamed Gaballa
    11482-11499

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit